Approval · Notice of Compliance 8255 · 2006
ACTONEL PLUS CALCIUM: Notice of Compliance 8255
Issued September 12, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8255
- Date
- September 12, 2006
- Company
- Procter & Gamble Pharmaceuticals Canada, IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Therapeutic class
- Risedronate: bone metabolism regulator / calcium: calcium supplement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTONEL PLUS CALCIUM | Not yet assigned | — |
Medicinal ingredients
- RISEDRONATE SODIUM 35 MG per TAB
- CALCIUM CARBONATE 500 MG per TAB